Patent details

EP2776416 Title: PHARMACEUTICAL COMPOUNDS

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2776416
WO Application Number:
GB2012052806
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP12787847.8
WO Publication Number:
WO2013068769
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United Kingdom (GB)
Publications:

Dates

Filing date:
12/11/2012
Grant date:
13/01/2016
EP Publication Date:
17/09/2014
WO Publication Date:
16/05/2013
Claims Translations Received Date:
Claims Translation B1 Received Date:
12/04/2016
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
13/01/2016
EP B1 Publication Date:
13/01/2016
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
11/11/2032
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
06/03/2024
 
 

 

Name:
Pfizer Inc.
Address:
66 Hudson Boulevard East, 10001-2192, New York, NY, United States of America (US)

Historical Applicant/holder

From:
28/11/2022
To:
28/11/2022

 

Name:
REVIRAL LIMITED
Address:
Stevenage Bioscience Catalyst Gunnels Wood Road, SG1 2FX, Stevenage, United Kingdom (GB)

From:
28/11/2022
To:
06/03/2024

 

Name:
Pfizer Inc.
Address:
235 East 42nd Street, 10017, New York, NY, United States of America (US)

From:
13/01/2016
To:
28/11/2022

 

Name:
Re:Viral Ltd.
Address:
16 St. Martin's Le Grand, London EC1A 4EN, United Kingdom (GB)

Domicile Holder

Name:
ir. F.A. Geurts c.s.
From:
12/04/2016
Address:
Octrooibureau Vriesendorp & Gaade B.V. Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
To:

Inventor

1

Name:
COCKERILL, Stuart
Address:
London EC1A 4EN, United Kingdom (GB)

2

Name:
PILKINGTON, Christopher
Address:
London EC1A 4EN, United Kingdom (GB)

3

Name:
LUMLEY, James
Address:
London EC1A 4EN, United Kingdom (GB)

4

Name:
ANGELL, Richard
Address:
London EC1A 4EN, United Kingdom (GB)

5

Name:
MATHEWS, Neil
Address:
London EC1A 4EN, United Kingdom (GB)

Priority

Priority Patent Number:
201119538
Priority Date:
10/11/2011
Priority Country:
United Kingdom (GB)

Classification

IPC or IDT classification:
A61K 31/437; A61K 31/4439; A61K 31/538; A61P 31/14; C07D 401/06; C07D 403/06; C07D 413/06; C07D 471/10;

Publication

Bulletin

1

Bulletin Heading:
CO
Journal edition number:
50/22
Publication date:
14/12/2022
Description:
Changes in the Netherlands Patent Register

2

Bulletin Heading:
CO
Journal edition number:
50/22
Publication date:
14/12/2022
Description:
Changes in the Netherlands Patent Register

3

Bulletin Heading:
EP3
Journal edition number:
18/16
Publication date:
04/05/2016
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

4

Bulletin Heading:
EP2
Journal edition number:
02/16
Publication date:
13/01/2016
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
201602
Publication date:
13/01/2016
Description:
Grant (B1)

Deed

Change of Address

Change Kind/ Decision Type:
Owner
Deed Number:
RC202400526A
Date Registered:
06/03/2024
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
dr. R.C. van Duijvenbode c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC202202911B
Date Registered:
28/11/2022
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Pfizer Inc.
Address:
235 East 42nd Street, 10017, New York, NY, United States of America (US)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name
Deed Number:
RC202202911A
Date Registered:
28/11/2022
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
REVIRAL LIMITED
Address:
Stevenage Bioscience Catalyst Gunnels Wood Road, SG1 2FX, Stevenage, United Kingdom (GB)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
30/11/2025
Annual Fee Number:
14
Annual Fee Amount:
800 Euro
Last Annual Payment Date:
14/10/2024
Last Annual Fee Paid Number:
13
Last Annual Fee Paid Amount:
700 Euro
Payer:
Master Data Center
Filing date Document type Document Description Number of pages File Type
02/05/2016 Outgoing Correspondence Outgoing Letter 1 PDF /4/3/7/5/2/0800025734/docs/ep12787847.8_2_53339l271.pdf
12/04/2016 Incoming Correspondence Electronic Accompanying letter incoming document 2 PDF /4/3/7/5/2/0800025734/docs/ep12787847.8_0_incomingcorrespondenceelectronic20160412113906211.pdf
12/04/2016 Outgoing Correspondence Outgoing Letter 1 PDF /4/3/7/5/2/0800025734/docs/ep12787847.8_1_outgoingcorrespondence20160412113902689.pdf
12/04/2016 Claims Translated claims 5 PDF /4/3/7/5/2/0800025734/docs/ep12787847.8_3_claims20160412113905426.pdf